Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase II Study of the Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy and 5FU or Capecitabine With and Without Zometa in Patients With Locally Advanced Pancreatic Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03073785
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:46.338681+00:00
Published At
2025-05-25T00:00:00+00:00
Record Updated At
2025-05-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Adenocarcinoma", "Recurrent Pancreatic Carcinoma", "Stage I Pancreatic Cancer AJCC v6 and v7", "Stage IA Pancreatic Cancer AJCC v6 and v7", "Stage IB Pancreatic Cancer AJCC v6 and v7", "Stage II Pancreatic Cancer AJCC v6 and v7", "Stage IIA Pancreatic Cancer AJCC v6 and v7", "Stage IIB Pancreatic Cancer AJCC v6 and v7", "Stage III Pancreatic Cancer AJCC v6 and v7", "Stage IV Pancreatic Cancer AJCC v6 and v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-25"
protocolSection.identificationModule.nctId
"NCT03073785"
protocolSection.identificationModule.officialTitle
"A Randomized Phase II Study of the Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy and 5FU or Capecitabine With and Without Zometa in Patients With Locally Advanced Pancreatic Adenocarcinoma"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IA Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IB Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage II Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIA Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIB Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.